Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2017

Sep 12, 2017

30786_dirs_2017-09-12_8862ee2d-20c2-48ba-a777-f27bc610f9ac.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-09-10

Reporting Person: GOETZ JOHN (EVP, Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-10 Bio-Rad A Common Stock M 1200 Acquired 64993.3235 Direct
2017-09-10 Bio-Rad A Common Stock F 627 $218.42 Disposed 64366.3235 Direct
2017-09-11 Bio-Rad A Common Stock M 1900 Acquired 66266.3235 Direct
2017-09-11 Bio-Rad A Common Stock F 992 $218.86 Disposed 65274.3235 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-09-10 Restricted Stock Units $0 M 1200 Disposed Bio-Rad A Common Stock (1200) Direct
2017-09-11 Restricted Stock Units $0 M 300 Disposed Bio-Rad A Common Stock (300) Direct
2017-09-11 Restricted Stock Units $0 M 1600 Disposed Bio-Rad A Common Stock (1600) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F4: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

F5: The restricted stock units vest in five equal annual installments beginning September 11, 2016.